661 related articles for article (PubMed ID: 19432913)
1. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
3. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening among elderly urban women in a primary care setting.
Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
[TBL] [Abstract][Full Text] [Related]
6. Updated approach to screening for cervical cancer in older women.
Celentano DD
Geriatrics; 1988 Apr; 43(4):37-8, 40-4, 48. PubMed ID: 2832258
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-risk human papillomavirus in an inner-city population with atypical squamous cells of undetermined significance.
Allen GL; Klobocista MM; Sugarman S; Gravel K; Feldman D; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):63-5. PubMed ID: 19387124
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
Wright TC
Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
[TBL] [Abstract][Full Text] [Related]
9. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area.
Núñez-Troconis J; Delgado M; González J; Mindiola R; Velásquez J; Conde B; Whitby D; Munroe DJ
Invest Clin; 2009 Jun; 50(2):203-12. PubMed ID: 19662815
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
15. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy.
Massad LS; Verhulst SJ; Hagemeyer M; Brady P
J Low Genit Tract Dis; 2006 Oct; 10(4):252-5. PubMed ID: 17012992
[TBL] [Abstract][Full Text] [Related]
16. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
Morrell S; Taylor R; Wain G
J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
[TBL] [Abstract][Full Text] [Related]
17. What do women in the U.S. know about human papillomavirus and cervical cancer?
Tiro JA; Meissner HI; Kobrin S; Chollette V
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):288-94. PubMed ID: 17267388
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
19. Informational needs and the experiences of women with abnormal Papanicolaou smears.
Bertram CC; Magnussen L
J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
[TBL] [Abstract][Full Text] [Related]
20. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]